To investigate if
insulin-like growth factor-1 (IGF-1) provides neuroprotection to oligodendrocyte progenitor cells (OPCs) following
cerebral hypoxia-ischemia, a previously developed neonatal rat model of white matter damage was used in this study. Postnatal day 4 (P4) SD rat pups were subjected to bilateral common carotid artery
ligation, followed by exposure to 8%
oxygen for 10 min.
IGF-1 (0.5 microg) or vehicle was injected into the left ventricle after artery
ligation and before the hypoxic exposure.
Cerebral hypoxia-ischemia caused death of O4+ late OPCs in the P5 rat brain and impaired myelination in the P9 and P21 rat brain.
Caspase-3 activation was involved in the death of OPCs. Moreover,
cerebral hypoxia-ischemia impaired neurobehavioral performance in juvenile rats.
IGF-1 treatment attenuated damages to OPCs and improved neurological functions after
cerebral hypoxia-ischemia. It reduced death of O4+ OPCs by 39% on P5 and enhanced myelination on P9 and P21.
Bromodeoxyuridine uptake assay showed that
cerebral hypoxia-ischemia inhibited proliferation of stem/progenitor cells in the subventricular zone and NG2+ early OPCs in the white matter area.
IGF-1 treatment increased cell proliferation in the subventricular zone by 31% 1 day following hypoxic-ischemic insult. Proliferation of early and late OPCs in the IGF-1-treated group was 1.5- and 2.4-fold of that in the vehicle-treated group, respectively. In conclusion,
IGF-1 provided potent neuroprotection to OPCs and improved neurological functions following
cerebral hypoxia-ischemia in the neonatal rat. The neuroprotection of
IGF-1 was associated with its antiapoptotic and mitogenic effects.